{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:49:08Z","timestamp":1773964148156,"version":"3.50.1"},"reference-count":45,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-10-C-1066"],"award-info":[{"award-number":["HDTRA1-10-C-1066"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2015.01509","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T01:27:14Z","timestamp":1452130034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Inflammatory Biomarkers Associated with Lethal Rift Valley Fever Encephalitis in the Lewis Rat Model"],"prefix":"10.3389","volume":"6","author":[{"given":"Amy L.","family":"Caroline","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Kujawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim D.","family":"Oury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas S.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1086\/345671","article-title":"Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans.","volume":"36","author":"Al-Hazmi","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF01310824","article-title":"The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis.","volume":"102","author":"Anderson","year":"1988","journal-title":"Arch. Virol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4269\/ajtmh.2010.09-0293","article-title":"Risk factors for severe Rift Valley fever infection in Kenya, 2007.","volume":"83","author":"Anyangu","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"105","key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2012.00105","article-title":"Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley fever virus.","volume":"2","author":"Bales","year":"2012","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0924-8579(02)00295-9","article-title":"Rift Valley fever: an uninvited zoonosis in the Arabian peninsula.","volume":"21","author":"Balkhy","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/infdis\/174.5.1098","article-title":"Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.","volume":"174","author":"Bernasconi","year":"1996","journal-title":"J. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift Valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals.","volume":"82","author":"Bird","year":"2008","journal-title":"J. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.virol.2007.01.046","article-title":"Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease.","volume":"362","author":"Bird","year":"2007a","journal-title":"Virology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1128\/JCM.00936-07","article-title":"Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus.","volume":"45","author":"Bird","year":"2007b","journal-title":"J. Clin. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jviromet.2004.03.015","article-title":"Virus inactivation by nucleic acid extraction reagents.","volume":"119","author":"Blow","year":"2004","journal-title":"J. Virol. Methods"},{"issue":"e2790","key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002790","article-title":"Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley fever.","volume":"8","author":"Caroline","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"19506","key":"B12","article-title":"Rift Valley fever\u2013a threat for Europe?","volume":"15","author":"Chevalier","year":"2010","journal-title":"Euro. Surveill."},{"key":"B13","first-page":"13294","article-title":"42 CFR Parts 72, 73 and 42 CFR Part 1003. Posession, Use, and Transfer of Select Agents and Toxins; final rule.","volume":"70","author":"Department of Health and Human Services","year":"2005","journal-title":"Federal Regist."},{"key":"B14","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1128\/JVI.00337-13","article-title":"Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.","volume":"87","author":"Dodd","year":"2013","journal-title":"J. Virol."},{"issue":"e2874","key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002874","article-title":"Rift Valley fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model.","volume":"8","author":"Dodd","year":"2014","journal-title":"PLoS Negl. Trop Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.4049\/jimmunol.1000949","article-title":"A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley fever.","volume":"185","author":"do Valle","year":"2010","journal-title":"J. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.antiviral.2013.03.009","article-title":"Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.","volume":"98","author":"Gowen","year":"2013","journal-title":"Antiviral Res."},{"issue":"e1529","key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001529","article-title":"Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse.","volume":"6","author":"Gray","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"e1","key":"B19","doi-asserted-by":"publisher","DOI":"10.3201\/eid1708.101088","article-title":"Potential effects of Rift Valley fever in the United States.","volume":"17","author":"Hartley","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1128\/JVI.02341-13","article-title":"Aerosolized Rift Valley fever virus causes fatal encephalitis in African green monkeys and common marmosets.","volume":"88","author":"Hartman","year":"2014","journal-title":"J. Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/0035-9203(79)90005-1","article-title":"The Rift Valley fever epizootic in Egypt 1977-78. 2. Ecological and entomological studies.","volume":"73","author":"Hoogstraal","year":"1979","journal-title":"Trans. R. Soc. Trop Med. Hyg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0923-2516(89)80096-2","article-title":"Analytical study of a Rift Valley fever epidemic.","volume":"140","author":"Jouan","year":"1989","journal-title":"Res. Virol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2010.02.017","article-title":"Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation.","volume":"473","author":"Kalita","year":"2010","journal-title":"Neurosci. Lett."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/jmv.21808","article-title":"Comparison of the levels of human herpesvirus 6 (HHV-6) DNA and cytokines in the cerebrospinal fluid and serum of children with HHV-6 encephalopathy.","volume":"82","author":"Kawabe","year":"2010","journal-title":"J. Med. Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4081\/gh.2012.134","article-title":"A temperature-limited assessment of the risk of Rift Valley fever transmission and establishment in the continental United States of America.","volume":"6","author":"Konrad","year":"2012","journal-title":"Geospat. Health"},{"issue":"e0003548","key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003548","article-title":"Factors associated with severe human Rift Valley fever in Sangailu, Garissa County, Kenya.","volume":"9","author":"LaBeaud","year":"2015","journal-title":"PLoS Negl. Trop Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/0035-9203(79)90006-3","article-title":"Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness.","volume":"73","author":"Laughlin","year":"1979","journal-title":"Trans. R. Soc. Trop Med. Hyg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics.","volume":"37","author":"Madani","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.virol.2011.09.023","article-title":"Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection.","volume":"422","author":"McElroy","year":"2012","journal-title":"Virology"},{"key":"B30","first-page":"803","article-title":"Rift Valley fever in humans in South Africa.","volume":"58","author":"McIntosh","year":"1980","journal-title":"S. Afr. Med. J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/0035-9203(79)90004-X","article-title":"The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizootic and virological studies.","volume":"73","author":"Meegan","year":"1979","journal-title":"Trans. R. Soc. Trop Med. Hyg."},{"key":"B32","first-page":"114","article-title":"Clinical experience with Rift Valley fever in humans during the 1977 Egyptian epizootic.","volume":"3","author":"Meegan","year":"1981","journal-title":"Contr. Epidem. Biostatist."},{"key":"B33","doi-asserted-by":"publisher","first-page":"9553","DOI":"10.1128\/JVI.03421-13","article-title":"Defining the chemokine basis for leukocyte recruitment during viral encephalitis.","volume":"88","author":"Michlmayr","year":"2014","journal-title":"J. Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4269\/ajtmh.2010.09-0318","article-title":"Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007.","volume":"83","author":"Mohamed","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1212\/01.wnl.0000208433.34723.65","article-title":"Monocyte chemoattractant protein-1 correlates with subcortical brain injury in HIV infection.","volume":"66","author":"Ragin","year":"2006","journal-title":"Neurology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/2049-632X.12157","article-title":"Differences in aerosolization of Rift Valley fever virus resulting from choice of inhalation exposure chamber: implications for animal challenge studies.","volume":"71","author":"Reed","year":"2014","journal-title":"Pathog Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/030098589202900602","article-title":"Rift Valley fever virus-induced encephalomyelitis and hepatitis in calves.","volume":"29","author":"Rippy","year":"1992","journal-title":"Vet. Pathol."},{"issue":"e20472","key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020472","article-title":"Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cells.","volume":"6","author":"Ruzek","year":"2011","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/0035-9203(80)90074-7","article-title":"Ocular disease resulting from infection with Rift Valley fever virus.","volume":"74","author":"Siam","year":"1980","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/bjo.64.5.366","article-title":"Rift Valley fever ocular manifestations: observations during the 1977 epidemic in Egypt.","volume":"64","author":"Siam","year":"1980","journal-title":"Br. J. Ophthalmol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.virol.2010.08.016","article-title":"The pathogenesis of Rift Valley fever virus in the mouse model.","volume":"407","author":"Smith","year":"2010","journal-title":"Virology"},{"key":"B42","first-page":"13241","article-title":"7 CFR Part 331 and 9 CFR Part 121. Agricultural Bioterrorism Protection Act of 2002; posession, use, and transfer of biological agents and toxins; final rule.","volume":"70","author":"United States Department of Agriculture [USDA]","year":"2005","journal-title":"Federal Regist."},{"key":"B43","first-page":"867","article-title":"Rift Valley fever affecting humans in South Africa: a clinicopathological study.","volume":"51","author":"van Velden","year":"1977","journal-title":"S. Afr. Med. J."},{"issue":"159","key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-015-0392-3","article-title":"Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease.","volume":"12","author":"van Vuren","year":"2015","journal-title":"Virol J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.antiviral.2009.10.008","article-title":"Present and future arboviral threats.","volume":"85","author":"Weaver","year":"2010","journal-title":"Antiviral Res."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T10:32:05Z","timestamp":1454581925000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2015.01509\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,7]]},"references-count":45,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2015.01509","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,7]]}}}